Intelligent Bio Solutions (INBS) Total Current Liabilities (2020 - 2025)
Intelligent Bio Solutions has reported Total Current Liabilities over the past 5 years, most recently at $5.5 million for Q2 2024.
- For Q2 2024, Total Current Liabilities fell 7.36% year-over-year to $5.5 million; the TTM value through Jun 2024 reached $5.5 million, down 7.36%, while the annual FY2024 figure was $5.5 million, 7.36% down from the prior year.
- Total Current Liabilities for Q2 2024 was $5.5 million at Intelligent Bio Solutions, down from $5.7 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $7.7 million in Q2 2020 and troughed at $1.2 million in Q4 2020.
- A 5-year average of $4.4 million and a median of $4.5 million in 2022 define the central range for Total Current Liabilities.
- On a YoY basis, Total Current Liabilities climbed as much as 243.73% in 2021 and fell as far as 52.11% in 2021.
- Year by year, Total Current Liabilities stood at $1.2 million in 2020, then surged by 243.73% to $4.0 million in 2021, then rose by 20.08% to $4.8 million in 2022, then increased by 7.65% to $5.2 million in 2023, then increased by 5.16% to $5.5 million in 2024.
- Business Quant data shows Total Current Liabilities for INBS at $5.5 million in Q2 2024, $5.7 million in Q1 2024, and $5.2 million in Q4 2023.